Clinical and Experimental Medicine

, Volume 6, Issue 4, pp 191–193

Atorvastatin decreases serum levels of advanced glycation end products (AGEs) in patients with type 2 diabetes

  • Y. Jinnouchi
  • S. Yamagishi
  • M. Takeuchi
  • S. Ishida
  • Y. Jinnouchi
  • J. Jinnouchi
  • T. Imaizumi
LETTER TO THE EDITOR

DOI: 10.1007/s10238-006-0115-6

Cite this article as:
Jinnouchi, Y., Yamagishi, S., Takeuchi, M. et al. Clin. Exper.Med. (2006) 6: 191. doi:10.1007/s10238-006-0115-6

Key words

AGEs Oxidative stress Diabetes Statin 

Copyright information

© Springer-Verlag Italia 2006

Authors and Affiliations

  • Y. Jinnouchi
    • 1
    • 4
  • S. Yamagishi
    • 1
  • M. Takeuchi
    • 2
  • S. Ishida
    • 3
  • Y. Jinnouchi
    • 1
    • 4
  • J. Jinnouchi
    • 4
  • T. Imaizumi
    • 1
  1. 1.Department of Internal Medicine, Division of Cardio-Vascular MedicineKurume University School of MedicineKurume 830-0011Japan
  2. 2.Department of Pathophysiological ScienceHokuriku UniversityKanazawaJapan
  3. 3.Ishida ClinicTosuJapan
  4. 4.Sasaguri HospitalKasuyaJapan

Personalised recommendations